Investors Look to Capitalize on the Budding Green Revolution
Lithium is the uncontested fuel of the green energy revolution. One little-known small-cap lithium mining company in a renowned South American location has started attracting interest from opportunity-minded investors.
Discover this company's HUGE lithium potential
Juan Andres, insider at Moderna

Juan Andres Insider Information

Insider of Moderna
As Chief Technical Operations and Quality Officer, Juan Andres is responsible for the supply of product required for Moderna’s preclinical and clinical development programs, as well as scaling the CMC (chemistry, manufacturing and controls) processes across Moderna’s portfolio. Mr. Andres also will lead all CMC late-stage development and future commercialization activities.

Mr. Andres was previously the Global Head of Technical Operations (Manufacturing and Supply Chain) for over 25,000 Novartis employees across all of its divisions. In this role, he had responsibility for all of Novartis’ manufacturing sites, and related support functions and technologies worldwide, overseeing small molecules drug substance and drug product, as well as biologics drug substance, drug product and technical development. Mr. Andres’ previous roles at Novartis included Group Novartis Quality Head, Global Head of Technical Research and Development, and Global Pharmaceutical Operations Head. Prior to Novartis, Mr. Andres worked at Eli Lilly & Co. for 18 years in a variety of manufacturing, production and quality roles in the United States, Puerto Rico, UK and Spain, most recently serving as Vice President, Pharmaceutical Manufacturing.

Mr. Andres holds a Master degree in Pharmacy from Alcala de Henares University in Madrid and completed an advanced development program at the London Business School.

What is Juan Andres' net worth?

The estimated net worth of Juan Andres is at least $1.81 million as of August 3rd, 2022. Mr. Andres owns 10,367 shares of Moderna stock worth more than $1,811,011 as of August 11th. This net worth evaluation does not reflect any other assets that Mr. Andres may own. Additionally, Mr. Andres receives an annual salary of $1,600,000.00 as Insider at Moderna. Learn More about Juan Andres' net worth.

How old is Juan Andres?

Mr. Andres is currently 57 years old. There are 5 older executives and no younger executives at Moderna. The oldest executive at Moderna is Mr. David W. Meline, Chief Financial Officer, who is 65 years old. Learn More on Juan Andres' age.

What is Juan Andres' salary?

As the Insider of Moderna, Inc., Mr. Andres earned a total compensation package of $4,247,823.00 in 2020. Mr. Andres earned a salary of $548,712.00, a bonus of $662,400.00, stock awards of $750,000.00, options awards of $2,250,000.00, and other compensation of $36,711.00.There are 3 executives that earn more than Mr. Andres. The highest earning executive at Moderna is Mr. Stephane Bancel, CEO & Director, who commands a salary of $3,160,000.00 per year. Learn More on Juan Andres' salary.

How do I contact Juan Andres?

The corporate mailing address for Mr. Andres and other Moderna executives is 200 TECHNOLOGY SQUARE, CAMBRIDGE MA, 02139. Moderna can also be reached via phone at (617) 714-6500 and via email at [email protected] Learn More on Juan Andres' contact information.

Has Juan Andres been buying or selling shares of Moderna?

During the past quarter, Juan Andres has sold $2,539,440.00 in Moderna stock. Most recently, Juan Andres sold 2,000 shares of the business's stock in a transaction on Wednesday, August 3rd. The shares were sold at an average price of $167.99, for a transaction totalling $335,980.00. Following the completion of the sale, the insider now directly owns 10,367 shares of the company's stock, valued at $1,741,552.33. Learn More on Juan Andres' trading history.

Who are Moderna's active insiders?

Moderna's insider roster includes Noubar Afeyan (Director), Juan Andres (Insider), Stephane Bancel (CEO), W. Cornwell (Director), Lori Henderson (General Counsel), Lori Henderson (General Counsel), Stephen Hoge (President), Lorence Kim (CFO), Shannon Klinger (Insider), David Meline (CFO), Elizabeth Nabel (Director), Paul Sagan (Director), and Tal Zaks (Insider). Learn More on Moderna's active insiders.

Are insiders buying or selling shares of Moderna?

During the last year, insiders at the sold shares 157 times. They sold a total of 1,583,333 shares worth more than $368,915,364.39. The most recent insider tranaction occured on August, 4th when CEO Stephane Bancel sold 40,000 shares worth more than $7,717,600.00. Insiders at Moderna own 17.3 % of the company. Learn More about insider trades at Moderna.

Information on this page was last updated on 8/4/2022.

Juan Andres Insider Trading History at Moderna

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/3/2022Sell2,000$167.99$335,980.0010,367View SEC Filing Icon  
7/27/2022Sell2,000$161.00$322,000.0010,367View SEC Filing Icon  
7/20/2022Sell2,000$167.00$334,000.0010,367View SEC Filing Icon  
7/13/2022Sell2,000$168.88$337,760.0010,367View SEC Filing Icon  
7/6/2022Sell2,000$154.85$309,700.0010,367View SEC Filing Icon  
7/1/2022Sell6,000$150.00$900,000.0010,367View SEC Filing Icon  
5/31/2022Sell749$145.40$108,904.6010,367View SEC Filing Icon  
5/10/2022Sell195$133.71$26,073.459,309View SEC Filing Icon  
5/4/2022Sell2,000$153.23$306,460.009,069View SEC Filing Icon  
4/29/2022Sell2,000$150.00$300,000.009,069View SEC Filing Icon  
4/20/2022Sell2,000$153.00$306,000.009,069View SEC Filing Icon  
4/13/2022Sell2,000$158.37$316,740.009,069View SEC Filing Icon  
4/6/2022Sell2,000$157.50$315,000.009,069View SEC Filing Icon  
3/30/2022Sell2,000$182.79$365,580.00View SEC Filing Icon  
3/23/2022Sell2,000$184.66$369,320.00View SEC Filing Icon  
3/16/2022Sell2,000$150.01$300,020.00View SEC Filing Icon  
2/24/2022Sell2,000$150.00$300,000.00View SEC Filing Icon  
2/16/2022Sell2,000$150.00$300,000.00View SEC Filing Icon  
2/9/2022Sell2,000$154.26$308,520.00View SEC Filing Icon  
2/2/2022Sell2,000$170.89$341,780.00View SEC Filing Icon  
12/29/2021Sell5,000$240.00$1,200,000.00View SEC Filing Icon  
12/27/2021Sell10,000$243.10$2,431,000.00View SEC Filing Icon  
12/22/2021Sell5,000$264.26$1,321,300.00View SEC Filing Icon  
12/20/2021Sell15,000$320.97$4,814,550.00View SEC Filing Icon  
12/17/2021Sell5,000$275.68$1,378,400.00View SEC Filing Icon  
12/15/2021Sell5,000$272.11$1,360,550.00View SEC Filing Icon  
12/13/2021Sell5,000$257.01$1,285,050.00View SEC Filing Icon  
12/10/2021Sell5,000$235.00$1,175,000.00View SEC Filing Icon  
12/8/2021Sell5,000$282.35$1,411,750.00View SEC Filing Icon  
12/6/2021Sell15,000$280.60$4,209,000.00View SEC Filing Icon  
12/3/2021Sell5,000$318.40$1,592,000.00View SEC Filing Icon  
11/29/2021Sell5,000$370.38$1,851,900.00View SEC Filing Icon  
11/26/2021Sell5,000$319.62$1,598,100.00View SEC Filing Icon  
11/24/2021Sell5,000$273.01$1,365,050.00View SEC Filing Icon  
11/22/2021Sell15,000$268.18$4,022,700.00View SEC Filing Icon  
11/19/2021Sell5,000$265.71$1,328,550.00View SEC Filing Icon  
11/17/2021Sell5,000$234.57$1,172,850.00View SEC Filing Icon  
11/15/2021Sell5,000$231.01$1,155,050.00View SEC Filing Icon  
11/10/2021Sell5,000$230.00$1,150,000.00View SEC Filing Icon  
11/8/2021Sell15,000$233.13$3,496,950.00View SEC Filing Icon  
11/5/2021Sell5,000$240.00$1,200,000.00View SEC Filing Icon  
11/1/2021Sell5,000$335.00$1,675,000.00View SEC Filing Icon  
10/29/2021Sell5,000$344.49$1,722,450.00View SEC Filing Icon  
10/27/2021Sell5,000$344.25$1,721,250.00View SEC Filing Icon  
10/25/2021Sell15,000$327.36$4,910,400.00View SEC Filing Icon  
10/22/2021Sell5,000$333.00$1,665,000.00View SEC Filing Icon  
10/20/2021Sell5,000$333.90$1,669,500.00View SEC Filing Icon  
10/18/2021Sell5,000$322.26$1,611,300.00View SEC Filing Icon  
10/15/2021Sell5,000$341.25$1,706,250.00View SEC Filing Icon  
10/13/2021Sell5,000$314.90$1,574,500.00View SEC Filing Icon  
10/6/2021Sell5,000$318.23$1,591,150.00View SEC Filing Icon  
9/29/2021Sell5,000$393.44$1,967,200.00View SEC Filing Icon  
9/27/2021Sell15,000$429.38$6,440,700.00View SEC Filing Icon  
9/27/2021Sell15,000$429.38$6,440,700.00View SEC Filing Icon  
9/22/2021Sell5,000$433.00$2,165,000.00View SEC Filing Icon  
9/20/2021Sell5,000$417.62$2,088,100.00View SEC Filing Icon  
9/17/2021Sell5,000$438.24$2,191,200.00View SEC Filing Icon  
9/15/2021Sell5,000$427.13$2,135,650.00View SEC Filing Icon  
9/13/2021Sell15,000$447.41$6,711,150.00View SEC Filing Icon  
9/10/2021Sell5,000$461.85$2,309,250.005,000View SEC Filing Icon  
9/1/2021Sell5,000$381.82$1,909,100.00View SEC Filing Icon  
8/30/2021Sell15,000$368.93$5,533,950.00View SEC Filing Icon  
8/27/2021Sell5,000$398.12$1,990,600.005,000View SEC Filing Icon  
8/25/2021Sell5,000$391.59$1,957,950.00View SEC Filing Icon  
8/18/2021Sell5,000$407.00$2,035,000.005,000View SEC Filing Icon  
8/13/2021Sell5,000$405.00$2,025,000.005,000View SEC Filing Icon  
8/4/2021Sell5,000$384.85$1,924,250.005,000View SEC Filing Icon  
7/28/2021Sell5,000$332.92$1,664,600.00View SEC Filing Icon  
7/23/2021Sell5,000$330.90$1,654,500.005,000View SEC Filing Icon  
7/21/2021Sell5,000$299.00$1,495,000.005,000View SEC Filing Icon  
7/19/2021Sell15,000$284.40$4,266,000.00View SEC Filing Icon  
7/16/2021Sell5,000$276.51$1,382,550.00View SEC Filing Icon  
7/14/2021Sell5,000$237.22$1,186,100.00View SEC Filing Icon  
7/12/2021Sell5,000$230.71$1,153,550.00View SEC Filing Icon  
7/6/2021Sell5,000$229.62$1,148,100.00View SEC Filing Icon  
6/23/2021Sell5,000$219.65$1,098,250.005,000View SEC Filing Icon  
6/21/2021Sell5,000$200.86$1,004,300.005,000View SEC Filing Icon  
6/14/2021Sell5,000$213.32$1,066,600.005,000View SEC Filing Icon  
6/7/2021Sell5,000$207.04$1,035,200.005,000View SEC Filing Icon  
5/17/2021Sell5,000$159.23$796,150.00
5/5/2021Sell5,000$178.34$891,700.005,000View SEC Filing Icon  
5/3/2021Sell5,000$183.66$918,300.00
4/28/2021Sell5,000$182.32$911,600.005,000View SEC Filing Icon  
4/26/2021Sell5,000$171.77$858,850.005,000View SEC Filing Icon  
4/21/2021Sell5,000$158.60$793,000.005,000View SEC Filing Icon  
4/19/2021Sell5,000$166.17$830,850.005,000View SEC Filing Icon  
4/14/2021Sell5,000$153.75$768,750.005,000View SEC Filing Icon  
4/7/2021Sell5,000$131.63$658,150.005,000View SEC Filing Icon  
3/31/2021Sell5,000$121.10$605,500.00
3/29/2021Sell5,000$130.05$650,250.005,000View SEC Filing Icon  
3/17/2021Sell5,000$149.78$748,900.005,000View SEC Filing Icon  
3/10/2021Sell5,000$133.24$666,200.005,000View SEC Filing Icon  
2/1/2021Sell5,000$172.99$864,950.005,000View SEC Filing Icon  
1/11/2021Sell5,000$112.83$564,150.005,000View SEC Filing Icon  
5/13/2020Sell127,500$64.67$8,245,425.00127,500View SEC Filing Icon  
5/1/2020Sell25,000$48.05$1,201,250.0025,000View SEC Filing Icon  
4/15/2020Sell23,403$37.11$868,485.3323,403View SEC Filing Icon  
4/6/2020Sell300$35.13$10,539.00300View SEC Filing Icon  
See Full Table

Juan Andres Buying and Selling Activity at Moderna

This chart shows Juan Andres's buying and selling at Moderna by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Moderna Company Overview

Moderna logo
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, respiratory syncytial virus, Endemic HCoV, and hMPV+PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, human immunodeficiency virus, herpes simplex virus, and varicella-zoster virus vaccines; and public health vaccines consists of Zika and Nipah vaccines. The company also offers systemic secreted and cell surface therapeutics; cancer vaccines, such as personalized cancer, KRAS, and checkpoint vaccines; intratumoral immuno-oncology products; localized regenerative, systemic intracellular, and inhaled pulmonary therapeutics. It has strategic alliances with AstraZeneca PLC; Merck & Co., Inc.; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Carisma Therapeutics, Inc.; Metagenomi, Inc.; the Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; and The Bill & Melinda Gates Foundation, as well as a collaboration and license agreement with Chiesi Farmaceutici S.P.A. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.
Read More

Today's Range

Now: $174.69
Low: $173.46
High: $179.85

50 Day Range

MA: $154.17
Low: $117.13
High: $194.18

2 Week Range

Now: $174.69
Low: $115.61
High: $464.85

Volume

68,063 shs

Average Volume

4,475,273 shs

Market Capitalization

$69.48 billion

P/E Ratio

5.32

Dividend Yield

N/A

Beta

1.61
How High Can Copper Go?
To power the green revolution, copper demand continues to skyrocket with no end in sight. Prices hit a 10-year high; as copper jumped 79% in the past year. Some analysts are calling for copper to rise another 50-100%! We may be at the beginning of a copper bull run the likes we've never seen before. Just how high can copper go?
Find Out in this Research Report.